Precision BioSciences, Inc. (DTIL)

NASDAQ: DTIL · IEX Real-Time Price · USD
1.55
-0.05 (-3.13%)
Jul 1, 2022 11:55 AM EDT - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017
Revenue
115.5324.2922.2410.886.48
Revenue Growth (YoY)
375.72%9.21%104.34%67.84%-
Gross Profit
115.5324.2922.2410.886.48
Selling, General & Admin
39.6936.0527.0313.678.02
Research & Development
115.2498.0682.4245.1220.32
Other Operating Expenses
00000.12
Operating Expenses
154.93134.11109.4458.828.46
Operating Income
-39.4-109.83-87.2-47.91-21.97
Interest Expense / Income
0.1300.1800
Other Expense / Income
-8.93-0.825.49-1.88-0.87
Pretax Income
-30.6-109.01-92.88-46.04-21.1
Net Income
-30.6-109.01-92.88-46.04-21.1
Net Income Common
-30.6-109.01-92.88-46.04-21.1
Shares Outstanding (Basic)
5952421616
Shares Outstanding (Diluted)
5952421616
Shares Change
12.79%23.91%166.18%-0.83%-
EPS (Basic)
-0.52-2.09-2.21-2.92-1.33
EPS (Diluted)
-0.52-2.09-2.21-2.92-1.33
Free Cash Flow Per Share
-0.27-1.78-2.28-4.27-1.87
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-34.11%-452.25%-392.14%-440.25%-338.90%
Profit Margin
-26.49%-448.86%-417.65%-423.02%-325.45%
Free Cash Flow Margin
-13.77%-380.55%-430.26%-619.19%-457.80%
EBITDA
-20.27-99.19-87.38-43.68-19.67
EBITDA Margin
-17.55%-408.45%-392.92%-401.39%-303.32%
Depreciation & Amortization
10.29.815.322.351.44
EBIT
-30.47-109.01-92.7-46.04-21.1
EBIT Margin
-26.37%-448.86%-416.83%-423.02%-325.45%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).